Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) Equity Average (2018 - 2026)

Neuronetics has reported Equity Average over the past 9 years, most recently at $19.8 million for Q1 2026.

  • Quarterly Equity Average fell 44.62% to $19.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $19.8 million through Mar 2026, down 44.62% year-over-year, with the annual reading at $29.0 million for FY2025, 12.05% down from the prior year.
  • Equity Average was $19.8 million for Q1 2026 at Neuronetics, down from $26.8 million in the prior quarter.
  • Over five years, Equity Average peaked at $80.9 million in Q1 2022 and troughed at $14.4 million in Q3 2024.
  • The 5-year median for Equity Average is $35.7 million (2025), against an average of $40.8 million.
  • Year-over-year, Equity Average tumbled 65.51% in 2024 and then skyrocketed 104.62% in 2025.
  • A 5-year view of Equity Average shows it stood at $60.0 million in 2022, then plummeted by 39.92% to $36.1 million in 2023, then plummeted by 42.91% to $20.6 million in 2024, then skyrocketed by 30.15% to $26.8 million in 2025, then dropped by 26.29% to $19.8 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's Equity Average are $19.8 million (Q1 2026), $26.8 million (Q4 2025), and $29.4 million (Q3 2025).